Location History:
- Encinitas, CA (US) (2022)
- San Diego, CA (US) (2006 - 2024)
Company Filing History:
3 out of 14 
3 out of 597 
1 out of 42 
Years Active: 2006-2024
Title: The Innovative Contributions of Patricia McNeeley
Introduction
Patricia McNeeley is a prominent inventor based in San Diego, California, known for her significant contributions to the field of biomedical research. With a total of four patents to her name, she has made remarkable strides in the development of therapeutic solutions for inflammatory bowel disease.
Latest Patents
Among her latest patents are the humanized antibodies to TNF-like ligand 1A (TL1A) and their uses. These patents describe humanized anti-TL1A antibodies and pharmaceutical compositions aimed at treating inflammatory bowel diseases, such as Crohn's Disease and ulcerative colitis. Her work in optimizing anti-TL1A antibodies further emphasizes her commitment to advancing medical treatments for these conditions.
Career Highlights
Throughout her career, Patricia has worked with notable organizations, including Prometheus Biosciences, Inc. and Cedars-Sinai Medical Center. Her experience in these institutions has allowed her to collaborate with leading experts in the field, enhancing her research and innovation capabilities.
Collaborations
Patricia has collaborated with esteemed colleagues, including Jeffry Dean Watkins and Cindy T. Dickerson. These partnerships have contributed to her success and the advancement of her research initiatives.
Conclusion
Patricia McNeeley's innovative work in the field of biomedical research showcases her dedication to improving treatments for inflammatory bowel disease. Her patents and collaborations reflect her significant impact on the medical community.